The prevalence of BRCA1/2 mutations is highest in ovarian cancer (21%) [4] and around 5% in several other cancers, including breast [5], prostate [6], pancreatic [7], non-small cell lung [8], bladder [9], and bile duct [10] cancers. Here, BRCA1 is linked to ovarian carcinoma.